Rising retail ownership, stretched expectations and past market parallels suggest speculative dynamics may be building in ...
A retrospective real-world analysis presented at the 2025 ASH Annual Meeting and Exposition showed that circulating tumor DNA (ctDNA) detected at the end of treatment (EOT) was a prognostic indicator ...
As AI reshapes biotechnology, stakeholders are acting to establish governance to maintain safety and efficacy standards.